Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/28471
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Buttery, SC | - |
dc.contributor.author | Lewis, A | - |
dc.contributor.author | Alzetani, A | - |
dc.contributor.author | Bolton, CE | - |
dc.contributor.author | Curtis, KJ | - |
dc.contributor.author | Dodd, JW | - |
dc.contributor.author | Habib, AM | - |
dc.contributor.author | Hussain, A | - |
dc.contributor.author | Havelock, T | - |
dc.contributor.author | Jordan, S | - |
dc.contributor.author | Kallis, C | - |
dc.contributor.author | Kemp, SV | - |
dc.contributor.author | Kirk, A | - |
dc.contributor.author | Lawson, RA | - |
dc.contributor.author | Mahadeva, R | - |
dc.contributor.author | Munavvar, M | - |
dc.contributor.author | Naidu, B | - |
dc.contributor.author | Rathinam, S | - |
dc.contributor.author | Shackcloth, M | - |
dc.contributor.author | Shah, PL | - |
dc.contributor.author | Tenconi, S | - |
dc.contributor.author | Hopkinson, NS | - |
dc.date.accessioned | 2024-03-04T19:13:05Z | - |
dc.date.available | 2024-03-04T19:13:05Z | - |
dc.date.issued | 2024-02-29 | - |
dc.identifier | ORCiD: S C Buttery https://orcid.org/0000-0001-9410-414X | - |
dc.identifier | ORCiD: Adam Lewis https://orcid.org/0000-0002-0576-8823 | - |
dc.identifier | ORCiD: A Alzetani https://orcid.org/0000-0002-3373-6714 | - |
dc.identifier | ORCiD: C E Bolton https://orcid.org/0000-0002-9578-2249 | - |
dc.identifier | ORCiD: A M Habib https://orcid.org/0000-0001-9919-1131 | - |
dc.identifier | ORCiD: N S Hopkinson https://orcid.org/0000-0003-3235-0454 | - |
dc.identifier | e002092 | - |
dc.identifier.citation | Buttery, S.C. et al. (2024) 'Survival following lung volume reduction procedures: results from the UK Lung Volume Reduction (UKLVR) registry', BMJ Open Respiratory Research, 11 (1), e002092, pp. 1 - 10 (+ 9 pp. of supplementary materials). doi: 10.1136/bmjresp-2023-002092. | en_US |
dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/28471 | - |
dc.description | Data availability statement: Data are available on reasonable request. All data relevant to the study are included in the article or uploaded as online supplemental information. | en_US |
dc.description | Supplementary materials: Supplementary Data are available online at: https://doi.org/10.1136/bmjresp-2023-002092 and are included on a file archived on this institutional repository | - |
dc.description.abstract | Introduction: Lung volume reduction surgery (LVRS) and endobronchial valve (EBV) placement can produce substantial benefits in appropriately selected people with emphysema. The UK Lung Volume Reduction (UKLVR) registry is a national multicentre observational study set up to support quality standards and assess outcomes from LVR procedures at specialist centres across the UK. Methods: Data were analysed for all patients undergoing an LVR procedure (LVRS/EBV) who were recruited into the study at participating centres between January 2017 and June 2022, including; disease severity and risk assessment, compliance with guidelines for selection, procedural complications and survival to February 2023. Results: Data on 541 patients from 14 participating centres were analysed. Baseline disease severity was similar in patients who had surgery n=244 (44.9%), or EBV placement n=219 (40.9%), for example, forced expiratory volume in 1 s (FEV1) 32.1 (12.1)% vs 31.2 (11.6)%. 89% of cases had discussion at a multidisciplinary meeting recorded. Median (IQR) length of stay postprocedure for LVRS and EBVs was 12 (13) vs 4 (4) days(p=0.01). Increasing age, male gender and lower FEV1%predicted were associated with mortality risk, but survival did not differ between the two procedures, with 50 (10.8%) deaths during follow-up in the LVRS group vs 45 (9.7%) following EBVs (adjusted HR 1.10 (95% CI 0.72 to 1.67) p=0.661) Conclusion: Based on data entered in the UKLVR registry, LVRS and EBV procedures for emphysema are being performed in people with similar disease severity and long-term survival is similar in both groups. | en_US |
dc.description.sponsorship | Imperial College London, Asthma Lung UK. | en_US |
dc.format.extent | 1 - 10 (+ 9 pp. of supplementary materials) | - |
dc.format.medium | Electronic | - |
dc.language | English | - |
dc.language.iso | en_US | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.rights | Copyright information: © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/. | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | - |
dc.title | Survival following lung volume reduction procedures: results from the UK Lung Volume Reduction (UKLVR) registry | en_US |
dc.type | Article | en_US |
dc.identifier.doi | https://doi.org/10.1136/bmjresp-2023-002092 | - |
dc.relation.isPartOf | BMJ Open Respiratory Research | - |
pubs.issue | 1 | - |
pubs.publication-status | Published | - |
pubs.volume | 11 | - |
dc.identifier.eissn | 2052-4439 | - |
dc.rights.license | https://creativecommons.org/licenses/by-nc/4.0/legalcode.en | - |
dc.rights.holder | Author(s) | - |
Appears in Collections: | Dept of Health Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | Copyright information: © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/. | 801.68 kB | Adobe PDF | View/Open |
FullTextWithSupplementaryMaterials.pdf | Copyright information: © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/. | 1.05 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License